Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8 <sup>+</sup> T Cells — Matthias Braun (2019) | RDL Network
Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Kimberley Stannard, Sophie Krumeich, Indrajit Das, Luize G. Lima, Lizeth G. Meza Guzman, Kunlun Li, Rui Li, Nazhifah Salim, Maria Villancanas Jorge, Sunyoung Ham, Gabrielle Kelly, Frank Vari, Ailin Lepletier, Ashwini Raghavendra, Sally‐Ann Pearson, Jason Madore, Sébastien Jacquelin, Maike Effern, Brodie Quine, Lambros T. Koufariotis, Mika Casey, Kyohei Nakamura, Eun Young Seo, Michael Hölzel, Matthias Geyer, Glen Kristiansen, Touraj Taheri, Elizabeth Ahern, Brett Hughes, James S. Wilmott, Georgina V. Long, Richard A Scolyer, Martin Batstone, Jennifer Landsberg, Dimo Dietrich, Oltin T. Pop, Lukas Flatz, William C. Dougall, André Veillette, Sandra E. Nicholson, Andreas Möller, Robert J. Johnston, Ludovic Martinet, Mark J. Smyth, Tobias Bald
A. Lepletier de Oliveira, Jason Madore, Jake S. O’Donnell, Rebecca L. Johnston, Melissa Eastgate, Domenico Mallardo, Paolo A. Ascierto, Daniela Massi, Barbara Merelli, Mario Mandalà, James S. Wilmott, Tobias Bald, J. C. A. Stagg, Bertrand Routy, Georgina V. Long, Richard A Scolyer, Nicola Waddell, William C. Dougall, Michele W.L. Teng, Mark J. Smyth
Sobha R. Bodduluri, Steven Mathis, Paramahamsa Maturu, E. Radha Krishnan, Shuchismita R. Satpathy, Paula M. Chilton, Thomas C. Mitchell, Sérgio A. Lira, Massimo Locati, Alberto Mantovani, Venkatakrishna R. Jala, Bodduluri Haribabu
Discussion(0)
No comments yet. Be the first to comment.